Price to Book Value Chart

View Price to Book Value for DYAI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value Chart
Start Trial

Historical Price to Book Value Data

View and export this data back to 2009. Start Trial.
Date Value
March 30, 2026 21.43
March 27, 2026 19.93
March 26, 2026 20.59
March 25, 2026 25.62
March 24, 2026 24.79
March 23, 2026 25.25
March 20, 2026 27.60
March 19, 2026 23.44
March 18, 2026 22.90
March 17, 2026 23.55
March 16, 2026 23.76
March 13, 2026 22.31
March 12, 2026 22.44
March 11, 2026 23.52
March 10, 2026 24.37
March 09, 2026 23.49
March 06, 2026 22.54
March 05, 2026 22.32
March 04, 2026 24.19
March 03, 2026 23.17
March 02, 2026 22.49
February 27, 2026 22.87
February 26, 2026 22.91
February 25, 2026 24.65
February 24, 2026 24.02
Date Value
February 23, 2026 23.49
February 20, 2026 23.34
February 19, 2026 23.54
February 18, 2026 23.82
February 17, 2026 23.63
February 13, 2026 24.37
February 12, 2026 24.22
February 11, 2026 23.36
February 10, 2026 24.45
February 09, 2026 24.46
February 06, 2026 25.00
February 05, 2026 24.94
February 04, 2026 24.87
February 03, 2026 24.96
February 02, 2026 25.28
January 30, 2026 25.57
January 29, 2026 26.57
January 28, 2026 25.81
January 27, 2026 25.96
January 26, 2026 25.80
January 23, 2026 26.42
January 22, 2026 26.78
January 21, 2026 26.08
January 20, 2026 26.00
January 16, 2026 25.55

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Agenus, Inc. --
Amgen, Inc. 17.78
Anika Therapeutics, Inc. 2.034
BioCryst Pharmaceuticals, Inc. --
Imunon, Inc. 1.771

Price to Book Value Related Metrics

PS Ratio 4.747
PEG Ratio -0.1676
Price 0.503
Earnings Yield -42.27%
Market Cap 18.33M
PEGY Ratio -0.1676